Home › Small Cell Lung Cancer › Texas › Dallas

Pag-aaral pangklinika para sa Small Cell Lung Cancer sa Dallas, TX

Isang pag-aaral para sa Small Cell Lung Cancer ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Dallas. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Nagre-recruitPhase 1/2

UT Southwest Simmons Cancer Center, Dallas

Edad 12 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT04585750

A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors

Nagre-recruitPhase 1

UT Southwestern, Dallas

Edad 19 pataas · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT06586957

Symbiotic-Lung-04: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Extensive-Stage Small Cell Lung Cancer

Nagre-recruitPhase 2/3

Texas Oncology - DFW, Dallas
Texas Oncology - DFW, Dallas
Texas Oncology - DFW, Dallas
at 2 pa

Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07226999

DESTINY-PANTUMOUR04

Nagre-recruitObservasyonal na pag-aaral

Research Site, Dallas

Edad 18 hanggang 130 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07124000

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

Nagre-recruitPhase 1/2

Baylor, Scott and White Research Institute, Dallas

Edad 18 pataas · Lahat ng kasarian · Na-update Set 24, 2026 · NCT06047379

A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer (DLLEVATE)

Nagre-recruitPhase 3

University of Texas Southwestern Medical Center/Clinical Research Department, Dallas

Edad 18 pataas · Lahat ng kasarian · Na-update Set 14, 2026 · NCT07218146

AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)

Nagre-recruitPhase 1/2

Avenzo Therapeutics Recruiting Site, Dallas

Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 4, 2026 · NCT07038343

A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer

Nagre-recruitPhase 1/2

Texas Oncology - DFW, Dallas

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 26, 2026 · NCT06892548

A First-in-human (FIH), Phase 1 Study of ML261, an Autologous Potency Enhanced Anti-DLL3 CAR T Cell Therapy, in Participants With R/R SCLC or Select NECs (SPECTRAL-1)

Nagre-recruitPhase 1

UT Southwestern Medical Center, Dallas

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT07488923

A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer

Nagre-recruitPhase 2

Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas
University of Texas Southwestern Medical Center, Dallas

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 17, 2026 · NCT06095505

Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors

Nagre-recruitPhase 1/2

NEXT Oncology - Dallas, Dallas

Edad 18 pataas · Lahat ng kasarian · Na-update Peb 18, 2026 · NCT07030257

JAB-2485 Activity in Adult Patients With Advanced Solid Tumors

Nagre-recruitPhase 1/2

Mary Crowley Cancer Research, Dallas

Edad 18 pataas · Lahat ng kasarian · Na-update Ene 9, 2026 · NCT05490472

A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors

Nagre-recruitPhase 1/2

Research Site 120, Dallas

Edad 18 pataas · Lahat ng kasarian · Na-update Nob 21, 2025 · NCT05914116

Pag-aaral para sa Small Cell Lung Cancer sa ibang lungsod

Iba pang pag-aaral sa Dallas

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.